Skycell AG's combination of advanced insulation and thermodynamic control provides landed-cost savings
At the LogiPharma meeting (Princeton, NJ; Sept. 16-18), Skycell AG updated its progress since introducing the company’s 770C Thermostable system to the US market last year. The Zurich, Switzerland company has worked through business and regulatory processes to enable shippers from Europe to convey products (generally delivered by air) to Brazil without the need to repackage products once they come off the aircraft—and while maintaining refrigerated temperature control through the entire importation and local-delivery process. This provides a competitive advantage relative to active unit-load devices (ULDs), which generally stay at the airport and are unloaded there.
The Thermostable system is a novel combination of gel-refrigerant and insulation technology. The pallet-size device has an outer plastic shell, a low-thermoconductivity insulation panel, and a “thermal barrier” panel that is essentially a gel pack set at a 6°C melt/freeze point. Within a defined time range, the unit loses cooling in hot environments, but gains it back in colder environments, which can extend the operating life of the unit substantially. IT is also designed with sustainability in mind; the outer and inner shells are recyclable plastics, and the entire unit weighs 270 kg (unloaded).
In the Brazil shipments that have been completed—for biologics going from Zurich to Sao Paulo--the company found that tarmac time (out of the aircraft and before delivery to a refrigerated warehouse) could range as high as 5 hours in 55°C temperatures; clearing customs could take as long as 21 days. Product was delivered safely at a 22% lower cost of operations than alternatives.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.